MedPath

Hydrocortisone acetate

Generic Name
Hydrocortisone acetate
Brand Names
Alcortin A, Analpram HC, Anodan-HC, Anucort-HC, Anusol, Anusol HC, Cortifoam, Cortisporin, Cortisporin-TC, Diphen, Egozinc, Epifoam, Fucidin, Micort-HC, Neo-polycin HC, Nucort, Pramosone, Procort 1.85/1.15, Proctocort, Proctodan-HC, Proctofoam-HC, Rectacort-HC, Rectogel, Riva-sol HC, U-cort, Vagisil, Vytone
Drug Type
Small Molecule
Chemical Formula
C23H32O6
CAS Number
50-03-3
Unique Ingredient Identifier
3X7931PO74

Overview

Not Available

Indication

For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.

Associated Conditions

  • Acute, Inflammatory Superficial Cutaneous Lesions caused by susceptible bacteria
  • Adrenocortical Insufficiency
  • Allergic Conjunctivitis (AC)
  • Anal inflammation
  • Androgenital syndrome
  • Conjunctivitis
  • Dermatitis infected
  • Diaper Dermatitis
  • Eczema infected
  • Episcleritis
  • Fissure;Anal
  • Haemorrhoids
  • Iridocyclitis
  • Iritis
  • Keratitis
  • Ocular Inflammation
  • Ocular Irritation
  • Postoperative pain
  • Proctitis
  • Pruritus
  • Pruritus Ani
  • Radiation Induced Proctitis
  • Rheumatoid Arthritis
  • Scleritis
  • Skin Infections
  • Skin Irritation
  • Superficial ocular bacterial infections caused by susceptible bacteria
  • Thyroiditis
  • Ulcerative Colitis
  • Anal eczema
  • Bacterial blepharitis
  • Corneal clouding
  • Corticosteroid responsive Dermatosis of the anal region
  • Corticosteroid-responsive dermatoses
  • Cryptitis
  • Localized uninfected hemorrhoids
  • Mild Anal Fissures
  • Pruritus associated with bowel movements
  • Skin and skin-structure infections caused by susceptible bacteria

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Cosette Pharmaceuticals, Inc.
0713-0503
RECTAL
25 mg in 1 1
11/22/2023
PureTek Corporation
59088-432
TOPICAL
10 mg in 1 g
1/11/2023
PureTek Corporation
59088-319
TOPICAL
10 mg in 1 g
3/15/2024
Vitruvias Therapeutics
69680-144
RECTAL
25 mg in 1 1
6/4/2021
A-S Medication Solutions
50090-6331
RECTAL
25 mg in 1 1
2/12/2020
Padagis US LLC
0574-4144
OPHTHALMIC
10 mg in 1 g
11/9/2018
Cameron Pharmaceuticals, Limited Liability Company
42494-342
RECTAL
30 mg in 1 1
7/1/2022
Padagis Israel Pharmaceuticals Ltd
45802-144
TOPICAL
1 g in 100 g
3/15/2018
Bryant Ranch Prepack
63629-1994
RECTAL
25 mg in 1 1
10/19/2021
Physicians Total Care, Inc.
54868-6122
OPHTHALMIC
10 mg in 1 g
5/17/2010

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
HYDRODERM CREAM 1%
SIN08804P
CREAM
1% w/w
7/3/1996
UCORT CREAM
SIN08726P
CREAM
10 mg/g
5/27/1996
HYDRODERM-C CREAM 1%
SIN08790P
CREAM
1% w/w
7/3/1996
MICON-H CREAM
SIN06454P
CREAM
1% w/w
7/17/1991
SW HYDROCORTISONE CREAM 1% w/w
SIN03781P
CREAM
1% w/w
1/18/1990
HYDROCORTISONE CREAM 1% w/w
SIN04767P
CREAM
1%
6/25/1990
FUCIDIN H CREAM
SIN10834P
CREAM
10 mg/g
3/24/1999
YSP HYDROCORT CREAM 1% W/W
SIN11172P
CREAM
10 mg/g
9/22/1999

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
LANACORT CRM 0.5%
00611301
Cream - Topical
.5 %
12/31/1987
CORTICREME 0.1%
rougier pharma division of ratiopharm inc
00477680
Cream - Topical
1 MG / G
12/31/1980
CORTACET CRM 0.5%
whitehall-robins inc.
01932381
Cream - Topical
0.5 %
12/31/1992
ANUSOL-HC OINTMENT
church & dwight canada corp
00505773
Ointment - Rectal
0.5 %
12/31/1981
SOPAMYCETIN/HC SUSP
laboratoires charton laboratories
00438669
Drops - Ophthalmic
1 %
12/31/1988
RECTOGEL HC
laboratoire riva inc.
00662461
Ointment - Rectal
1.0 %
5/26/1998
PENTAMYCETIN/HC
01980572
Suspension - Otic ,  Ophthalmic
10 MG / ML
12/31/1992
UREMOL HC
00560022
Lotion - Topical
1 %
12/31/1983
SANDOZ ANUZINC HC PLUS
02247692
Ointment - Topical ,  Rectal
5 MG / G
1/20/2004
PROCTODAN-HC SUPPOSITORIES
odan laboratories ltd
02240851
Suppository - Rectal
10 MG
3/23/2000

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.